These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35869469)

  • 1. Metabolic activity via
    Song J; Li Z; Yang L; Wei M; Yang Z; Wang X
    BMC Cancer; 2022 Jul; 22(1):808. PubMed ID: 35869469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Value of Metabolic Parameters Derived From
    Liu H; Ye Z; Yang T; Xie H; Duan T; Li M; Wu M; Song B
    Front Immunol; 2021; 12():724464. PubMed ID: 34512653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does high [
    Cha J; Kim H; Shin HJ; Lee M; Jun S; Kang WJ; Cho A
    Eur Radiol; 2023 Nov; 33(11):7450-7460. PubMed ID: 37338560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of intratumoral-metabolic heterogeneity derived from
    Zhang L; Liu Y; Ding Y; Deng Y; Chen H; Hu F; Fan J; Lan X; Cao W
    Front Oncol; 2023; 13():1065744. PubMed ID: 37182124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between
    Liu X; Wang SC; Ni M; Xie Q; Zhang YF; Lv WF; Geng GY
    Abdom Radiol (NY); 2022 Apr; 47(4):1255-1264. PubMed ID: 35138462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The correlation of
    Qu YH; Long N; Ran C; Sun J
    Clin Transl Oncol; 2021 Mar; 23(3):620-627. PubMed ID: 32683540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Microsatellite Instability in Colorectal Cancer Using a Machine Learning Model Based on PET/CT Radiomics.
    Kim S; Lee JH; Park EJ; Lee HS; Baik SH; Jeon TJ; Lee KY; Ryu YH; Kang J
    Yonsei Med J; 2023 May; 64(5):320-326. PubMed ID: 37114635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric cancers with microsatellite instability exhibit high fluorodeoxyglucose uptake on positron emission tomography.
    Chung HW; Lee SY; Han HS; Park HS; Yang JH; Lee HH; So Y
    Gastric Cancer; 2013 Apr; 16(2):185-92. PubMed ID: 22692466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of CT, FDG PET-CT and serum tumor markers in staging recurrent colorectal cancer.
    Caglar M; Yener C; Karabulut E
    Int J Comput Assist Radiol Surg; 2015 Jul; 10(7):993-1002. PubMed ID: 25213271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Intratumor Metabolic Heterogeneity Parameters on
    Liu X; Xiang K; Geng GY; Wang SC; Ni M; Zhang YF; Pan HF; Lv WF
    Contrast Media Mol Imaging; 2022; 2022():2586245. PubMed ID: 35173559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma.
    Son SH; Kang SM; Jeong SY; Lee SW; Lee SJ; Lee J; Ahn BC
    Clin Nucl Med; 2016 Jun; 41(6):e266-73. PubMed ID: 27055144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significant value of predicting prognosis in patients with colorectal cancer using
    Xu J; Li Y; Hu S; Lu L; Gao Z; Yuan H
    Ann Nucl Med; 2019 Jan; 33(1):32-38. PubMed ID: 30218280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations among KRAS Mutation, Microsatellite Instability, and 18F-FDG Uptake in Colon Cancer.
    Lee SS; Choi SJ; Park JS
    Asian Pac J Cancer Prev; 2022 Oct; 23(10):3501-3506. PubMed ID: 36308376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of metabolic tumor volume and total lesion glycolysis in patients with advanced cervical carcinoma.
    Calles-Sastre L; Mucientes-Rasilla J; San-Frutos Llorente LM; Royuela A; Garcia-Espantaleón Navas M; Herrero Gámiz S; Pérez-Medina T
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(1):17-21. PubMed ID: 30366731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer.
    Lee JW; Kang CM; Choi HJ; Lee WJ; Song SY; Lee JH; Lee JD
    J Nucl Med; 2014 Jun; 55(6):898-904. PubMed ID: 24711649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of preoperative metabolic tumour volume and total lesion glycolysis measured by (18)F-FDG PET/CT in squamous cell carcinoma of the oral cavity.
    Ryu IS; Kim JS; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY
    Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):452-61. PubMed ID: 24081448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the prognostic value of different methods of calculating the tumour metabolic volume with
    Guzmán Ortiz S; Mucientes Rasilla J; Vargas Núñez JA; Royuela A; Navarro Matilla B; Mitjavila Casanovas M
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(6):340-346. PubMed ID: 32646783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma.
    Liu DD; Li J; Li X; Xie L; Qin L; Peng F; Cheng MH
    J Gynecol Oncol; 2019 Nov; 30(6):e89. PubMed ID: 31576685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents.
    Hwang SH; Cho A; Yun M; Choi YD; Rha SY; Kang WJ
    Clin Nucl Med; 2017 May; 42(5):e235-e241. PubMed ID: 28288043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.